Keap Calm, and Carry on Covalently
The DOI matches its Crossref record; 137 of the 140 references it cites were found in a registry or an index.
Abstract
The Nrf2-Keap1 system plays a major role in cellular defense against oxidative stress. Upon exposure to electrophiles, the cysteine-rich protein Keap1 is covalently modified, and it is this modification of Keap1 that allows the accumulation and subsequent nuclear translocation of Nrf2 where it induces the transcription of over 100 protective genes. This mechanism can be exploited in drug discovery approaches to diseases such as chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), asthma, and neurodegenerative diseases like multiple sclerosis (MS) and Parkinson's, utilizing the modification of Keap1 by electrophiles, compounds that would not normally be considered useful in drug discovery programs. This Perspective discusses the development of potential therapies based on potent electrophiles, such as isothiocyanates and Michael acceptors, that, far from being associated with toxic events, can actually initiate a range of beneficial protective pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, some covalent inhibitors with reactive functional groups tend to be unattractive for drug discovery because of the poor pharmacokinetic values, especially high clearance [137].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [137]
Citations
Cites
2 retracted
Malhotra, D., Thimmulappa, R., Navas-Acien, A., Sandford, A., Elliott, M., Singh, A., Chen, L., Zhuang, X., Hogg, J., Pare, P., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-380oc · Cited by 357
RetractedMukherjee, S., Gangopadhyay, H., & Das, D. K. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0728146 · Cited by 124
RetractedItoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
BIOLOGY AND BIOCHEMISTRY OF GLUCOSINOLATES
Halkier, B. A., & Gershenzon, J. (2006) · Annual Review of Plant Biology · doi:10.1146/annurev.arplant.57.032905.105228 · Cited by 2,271
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Zhang, Y., Talalay, P., Cho, C. G., & Posner, G. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2399 · Cited by 1,682
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Taguchi, K., Motohashi, H., & Yamamoto, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01473.x · Cited by 1,478
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex
Zhang, D. D., Lo, S.-C., Cross, J. V., Templeton, D. J., & Hannink, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10941-10953.2004 · Cited by 1,254
Linker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain · doi:10.1093/brain/awq386 · Cited by 1,155
NRF2 and cancer: the good, the bad and the importance of context
Sporn, M. B., & Liby, K. T. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3278 · Cited by 1,067
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
Singh, A., Misra, V., Thimmulappa, R. K., Lee, H., Ames, S., Hoque, M. O., Herman, J. G., Baylin, S. B., Sidransky, D., Gabrielson, E., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030420 · Cited by 1,060
The cytoprotective role of the Keap1–Nrf2 pathway
Baird, L., & Dinkova-Kostova, A. T. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0674-5 · Cited by 1,027
Cullinan, S. B., Gordan, J. D., Jin, J., Harper, J. W., & Diehl, J. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8477-8486.2004 · Cited by 986
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pergola, P. E., Raskin, P., Toto, R. D., Meyer, C. J., Huff, J. W., Grossman, E. B., Krauth, M., Ruiz, S., Audhya, P., Christ-Schmidt, H., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105351 · Cited by 890
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Wang, X.-J., Sun, Z., Villeneuve, N. F., Zhang, S., Zhao, F., Li, Y., Chen, W., Yi, X., Zheng, W., Wondrak, G. T., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn095 · Cited by 839
Fahey, J. W., Haristoy, X., Dolan, P. M., Kensler, T. W., Scholtus, I., Stephenson, K. K., Talalay, P., & Lozniewski, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.112203099 · Cited by 795
Small Molecule Modulators of Keap1‐ Nrf2‐ ARE Pathway as Potential Preventive and Therapeutic Agents
Magesh, S., Chen, Y., & Hu, L. (2012) · Medicinal Research Reviews · doi:10.1002/med.21257 · Cited by 760
Tong, K. I., Katoh, Y., Kusunoki, H., Itoh, K., Tanaka, T., & Yamamoto, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.2887-2900.2006 · Cited by 759
Surh, Y.-J., Kundu, J., & Na, H.-K. (2008) · Planta Medica · doi:10.1055/s-0028-1088302 · Cited by 758
Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer
Padmanabhan, B., Tong, K. I., Ohta, T., Nakamura, Y., Scharlock, M., Ohtsuji, M., Kang, M.-I., Kobayashi, A., Yokoyama, S., & Yamamoto, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.013 · Cited by 735
Shibata, T., Ohta, T., Tong, K. I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M., & Hirohashi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806268105 · Cited by 728
Hemoprotein Bach1 regulates enhancer availability of heme oxygenase‐1 gene
Sun, J., Hoshino, H., Takaku, K., Nakajima, O., Muto, A., Suzuki, H., Tashiro, S., Takahashi, S., Shibahara, S., Alam, J., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf516 · Cited by 637
Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling
Lo, S., Li, X., Henzl, M. T., Beamer, L. J., & Hannink, M. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601243 · Cited by 604
Adam, J., Hatipoglu, E., O'Flaherty, L., Ternette, N., Sahgal, N., Lockstone, H., Baban, D., Nye, E., Stamp, G. W., Wolhuter, K., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.006 · Cited by 585
Dinkova-Kostova, A. T., Liby, K. T., Stephenson, K. K., Holtzclaw, W. D., Gao, X., Suh, N., Williams, C., Risingsong, R., Honda, T., Gribble, G. W., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500815102 · Cited by 569
Sulforaphane, a Dietary Component of Broccoli/Broccoli Sprouts, Inhibits Breast Cancer Stem Cells
Li, Y., Zhang, T., Korkaya, H., Liu, S., Lee, H.-F., Newman, B., Yu, Y., Clouthier, S. G., Schwartz, S. J., Wicha, M. S., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2937 · Cited by 559
Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles
Serafimova, I. M., Pufall, M. A., Krishnan, S., Duda, K., Cohen, M. S., Maglathlin, R. L., McFarland, J. M., Miller, R. M., Frödin, M., & Taunton, J. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.925 · Cited by 493
Shibata, T., Kokubu, A., Gotoh, M., Ojima, H., Ohta, T., Yamamoto, M., & Hirohashi, S. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.06.082 · Cited by 468
Scannevin, R. H., Chollate, S., Jung, M.-Y., Shackett, M., Patel, H., Bista, P., Zeng, W., Ryan, S., Yamamoto, M., Lukashev, M., et al. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.190132 · Cited by 461
Tong, K. I., Padmanabhan, B., Kobayashi, A., Shang, C., Hirotsu, Y., Yokoyama, S., & Yamamoto, M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00753-07 · Cited by 442
Pulmonary and Systemic Oxidant/Antioxidant Imbalance in Chronic Obstructive Pulmonary Disease
MacNee, W. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200411-056sf · Cited by 411
Liby, K. T., & Sporn, M. B. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.004846 · Cited by 405
McMahon, M., Thomas, N., Itoh, K., Yamamoto, M., & Hayes, J. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403061200 · Cited by 404
The cancer chemopreventive actions of phytochemicals derived from glucosinolates
Hayes, J. D., Kelleher, M. O., & Eggleston, I. M. (2008) · European Journal of Nutrition · doi:10.1007/s00394-008-2009-8 · Cited by 404
Ooi, A., Wong, J.-C., Petillo, D., Roossien, D., Perrier-Trudova, V., Whitten, D., Min, B. W. H., Tan, M.-H., Zhang, Z., Yang, X. J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.024 · Cited by 401
Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1
Reichard, J. F., Motz, G. T., & Puga, A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm638 · Cited by 394
Okawa, H., Motohashi, H., Kobayashi, A., Aburatani, H., Kensler, T. W., & Yamamoto, M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.185 · Cited by 387
Xu, C., Huang, M.-T., Shen, G., Yuan, X., Lin, W., Khor, T. O., Conney, A. H., & Kong, A.-N. T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0300 · Cited by 380
Iida, K., Itoh, K., Kumagai, Y., Oyasu, R., Hattori, K., Kawai, K., Shimazui, T., Akaza, H., & Yamamoto, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1906 · Cited by 370
Singh, A., Boldin-Adamsky, S., Thimmulappa, R. K., Rath, S. K., Ashush, H., Coulter, J., Blackford, A., Goodman, S. N., Bunz, F., Watson, W. H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1401 · Cited by 367
The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm
Zipper, L. M., & Mulcahy, R. T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206530200 · Cited by 366
Molecular Targets of Dietary Phenethyl Isothiocyanate and Sulforaphane for Cancer Chemoprevention
Cheung, K. L., & Kong, A.-N. (2010) · The AAPS Journal · doi:10.1208/s12248-009-9162-8 · Cited by 364
Harvey, C. J., Thimmulappa, R. K., Sethi, S., Kong, X., Yarmus, L., Brown, R. H., Feller-Kopman, D., Wise, R., & Biswal, S. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002042 · Cited by 342
Herr, I., & Büchler, M. W. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.01.002 · Cited by 334
Sun, Z., Zhang, S., Chan, J. Y., & Zhang, D. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00630-07 · Cited by 332
Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks
Barf, T., & Kaptein, A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3003203 · Cited by 331
Protective effect of sulforaphane against oxidative stress: Recent advances
Guerrero-Beltrán, C. E., Calderón-Oliver, M., Pedraza-Chaverri, J., & Chirino, Y. I. (2012) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2010.11.005 · Cited by 320
Molecular Basis of Electrophilic and Oxidative Defense: Promises and Perils of Nrf2
Ma, Q., & He, X. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.004333 · Cited by 317
Sporn, M. B., Liby, K. T., Yore, M. M., Fu, L., Lopchuk, J. M., & Gribble, G. W. (2011) · Journal of Natural Products · doi:10.1021/np100826q · Cited by 312
Suzuki, M., Betsuyaku, T., Ito, Y., Nagai, K., Nasuhara, Y., Kaga, K., Kondo, S., & Nishimura, M. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0424oc · Cited by 286
Wu, L., Ashraf, M. H. N., Facci, M., Wang, R., Paterson, P. G., Ferrie, A., & Juurlink, B. H. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402004101 · Cited by 286
Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases
Canning, P., Cooper, C. D. O., Krojer, T., Murray, J. W., Pike, A. C. W., Chaikuad, A., Keates, T., Thangaratnarajah, C., Hojzan, V., Marsden, B. D., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.437996 · Cited by 284
Liby, K., Hock, T., Yore, M. M., Suh, N., Place, A. E., Risingsong, R., Williams, C. R., Royce, D. B., Honda, T., Honda, Y., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4539 · Cited by 283
Electrophilic natural products and their biological targets
Gersch, M., Kreuzer, J., & Sieber, S. A. (2012) · Natural Product Reports · doi:10.1039/c2np20012k · Cited by 282
Validation of the multiple sensor mechanism of the Keap1-Nrf2 system
Takaya, K., Suzuki, T., Motohashi, H., Onodera, K., Satomi, S., Kensler, T. W., & Yamamoto, M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.023 · Cited by 276
Yanaka, A., Fahey, J. W., Fukumoto, A., Nakayama, M., Inoue, S., Zhang, S., Tauchi, M., Suzuki, H., Hyodo, I., & Yamamoto, M. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0192 · Cited by 276
A Sulforaphane Analogue That Potently Activates the Nrf2-dependent Detoxification Pathway
Morimitsu, Y., Nakagawa, Y., Hayashi, K., Fujii, H., Kumagai, T., Nakamura, Y., Osawa, T., Horio, F., Itoh, K., Iida, K., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110244200 · Cited by 273
Health benefits and possible risks of broccoli – An overview
Latté, K. P., Appel, K.-E., & Lampen, A. (2011) · Food and Chemical Toxicology · doi:10.1016/j.fct.2011.08.019 · Cited by 266
Mechanistic Basis of Enzyme-Targeted Drugs
Robertson, J. G. (2005) · Biochemistry · doi:10.1021/bi050247e · Cited by 248
Crystal Structure of the Kelch Domain of Human Keap1
Li, X., Zhang, D., Hannink, M., & Beamer, L. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410073200 · Cited by 246
Indole glucosinolate breakdown and its biological effects
Agerbirk, N., De Vos, M., Kim, J. H., & Jander, G. (2009) · Phytochemistry Reviews · doi:10.1007/s11101-008-9098-0 · Cited by 243
Honda, T., Rounds, B. V., Bore, L., Finlay, H. J., Favaloro, Suh, N., Wang, Y., Sporn, M. B., & Gribble, G. W. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm0002230 · Cited by 241
Glucosinolates and biofumigation: fate of glucosinolates and their hydrolysis products in soil
Gimsing, A. L., & Kirkegaard, J. A. (2009) · Phytochemistry Reviews · doi:10.1007/s11101-008-9105-5 · Cited by 240
Marcotte, D., Zeng, W., Hus, J.-C., McKenzie, A., Hession, C., Jin, P., Bergeron, C., Lugovskoy, A., Enyedy, I., Cuervo, H., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.04.019 · Cited by 239
Triterpenoid CDDO-Me Blocks the NF-κB Pathway by Direct Inhibition of IKKβ on Cys-179
Ahmad, R., Raina, D., Meyer, C., Kharbanda, S., & Kufe, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607160200 · Cited by 238
Hong, D. S., Kurzrock, R., Supko, J. G., He, X., Naing, A., Wheler, J., Lawrence, D., Eder, J. P., Meyer, C. J., Ferguson, D. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2703 · Cited by 236
Effect of Bardoxolone Methyl on Kidney Function in Patients with T2D and Stage 3b–4 CKD
Pergola, P. E., Krauth, M., Huff, J. W., Ferguson, D. A., Ruiz, S., Meyer, C. J., & Warnock, D. G. (2011) · American Journal of Nephrology · doi:10.1159/000327599 · Cited by 233
Ogura, T., Tong, K. I., Mio, K., Maruyama, Y., Kurokawa, H., Sato, C., & Yamamoto, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914036107 · Cited by 229
Small molecule modulators of antioxidant response pathway
Hur, W., & Gray, N. S. (2011) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.12.009 · Cited by 211
Honda, T., Rounds, B. V., Gribble, G. W., Suh, N., Wang, Y., & Sporn, M. B. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00479-x · Cited by 204
Discovery of a small-molecule inhibitor and cellular probe of Keap1–Nrf2 protein–protein interaction
Hu, L., Magesh, S., Chen, L., Wang, L., Lewis, T. A., Chen, Y., Khodier, C., Inoyama, D., Beamer, L. J., Emge, T. J., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.013 · Cited by 200
Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema
Goven, D., Boutten, A., Lecon-Malas, V, Marchal-Somme, J., Amara, N., Crestani, B., Fournier, M., Leseche, G., Soler, P., Boczkowski, J., et al. (2008) · Thorax · doi:10.1136/thx.2007.091181 · Cited by 195
Sites of alkylation of human Keap1 by natural chemoprevention agents
Luo, Y., Eggler, A. L., Liu, D., Liu, G., Mesecar, A. D., & van Breemen, R. B. (2007) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2007.09.015 · Cited by 190
The Keap1–Nrf2 system as an in vivo sensor for electrophiles
Uruno, A., & Motohashi, H. (2011) · Nitric Oxide · doi:10.1016/j.niox.2011.02.007 · Cited by 188
VanEtten, C. H., Daxenbichler, M. E., Williams, P. H., & Kwolek, W. F. (1976) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf60205a049 · Cited by 180
Higgins, L. G., Kelleher, M. O., Eggleston, I. M., Itoh, K., Yamamoto, M., & Hayes, J. D. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.03.005 · Cited by 177
Xiao, D., Powolny, A. A., Moura, M. B., Kelley, E. E., Bommareddy, A., Kim, S.-H., Hahm, E.-R., Normolle, D., Van Houten, B., & Singh, S. V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.063255 · Cited by 176
Eggler, A. L., Small, E., Hannink, M., & Mesecar, A. D. (2009) · Biochemical Journal · doi:10.1042/bj20090471 · Cited by 176
Kaidery, N. A., Banerjee, R., Yang, L., Smirnova, N. A., Hushpulian, D. M., Liby, K. T., Williams, C. R., Yamamoto, M., Kensler, T. W., Ratan, R. R., et al. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4491 · Cited by 170
Electrophilic tuning of the chemoprotective natural product sulforaphane
Ahn, Y.-H., Hwang, Y., Liu, H., Wang, X. J., Zhang, Y., Stephenson, K. K., Boronina, T. N., Cole, R. N., Dinkova-Kostova, A. T., Talalay, P., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004104107 · Cited by 169
Novel Chalcone Derivatives as Potent Nrf2 Activators in Mice and Human Lung Epithelial Cells
Kumar, V., Kumar, S., Hassan, M., Wu, H., Thimmulappa, R. K., Kumar, A., Sharma, S. K., Parmar, V. S., Biswal, S., & Malhotra, S. V. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2002348 · Cited by 165
Nrf2-dependent and -independent Responses to Nitro-fatty Acids in Human Endothelial Cells
Kansanen, E., Jyrkkänen, H.-K., Volger, O. L., Leinonen, H., Kivelä, A. M., Häkkinen, S.-K., Woodcock, S. R., Schopfer, F. J., Horrevoets, A. J., Ylä-Herttuala, S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064873 · Cited by 165
Regulation of Nrf2-dependent gene expression by 15-deoxy-Δ12,14-prostaglandin J2
Kansanen, E., Kivelä, A. M., & Levonen, A. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.030 · Cited by 164
Burger's medicinal chemistry, drug discovery, and development
Burger, A., Abraham, D. J., & Rotella, D. P. (2010) · Wiley eBooks · Cited by 164
Avonto, C., Taglialatela‐Scafati, O., Pollastro, F., Minassi, A., Di Marzo, V., De Petrocellis, L., & Appendino, G. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201005959 · Cited by 158
Posner, G. H., Cho, C.-G., Green, J. V., Zhang, Y., & Talalay, P. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00027a021 · Cited by 158
Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction
Hancock, R., Bertrand, H. C., Tsujita, T., Naz, S., El-Bakry, A., Laoruchupong, J., Hayes, J. D., & Wells, G. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.10.486 · Cited by 151
Cysteine-based regulation of the CUL3 adaptor protein Keap1
Sekhar, K. R., Rachakonda, G., & Freeman, M. L. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.06.016 · Cited by 151
Schmidt, T. J., Ak, M., & Mrowietz, U. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.053 · Cited by 143
Shimozono, R., Asaoka, Y., Yoshizawa, Y., Aoki, T., Noda, H., Yamada, M., Kaino, M., & Mochizuki, H. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.084269 · Cited by 134
Shikita, M., Fahey, J. W., Golden, T. R., Holtzclaw, W. D., & Talalay, P. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3410725 · Cited by 133
Oral Broccoli Sprouts for the Treatment of Helicobacter pylori Infection: A Preliminary Report
Galan, M. V., Kishan, A. A., & Silverman, A. L. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000037792.04787.8a · Cited by 115
Couch, R. D., Browning, R. G., Honda, T., Gribble, G. W., Wright, D. L., Sporn, M. B., & Anderson, A. C. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.03.031 · Cited by 110
Anti-inflammatory Effect of a Cell-Penetrating Peptide Targeting the Nrf2/Keap1 Interaction
Steel, R., Cowan, J., Payerne, E., O'Connell, M. A., & Searcey, M. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300041g · Cited by 108
Satyan, K. S., Swamy, N., Dizon, D. S., Singh, R., Granai, C. O., & Brard, L. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.03.002 · Cited by 107
An Exceptionally Potent Inducer of Cytoprotective Enzymes
Dinkova-Kostova, A. T., Talalay, P., Sharkey, J., Zhang, Y., Holtzclaw, W. D., Wang, X. J., David, E., Schiavoni, K. H., Finlayson, S., Mierke, D. F., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.163485 · Cited by 106
Lee, C. Y., Chew, E., & Go, M. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.03.023 · Cited by 103
Genotoxic effects of benzyl isothiocyanate, a natural chemopreventive agent
Kassie, F., Pool-Zobel, B. L., Parzefall, W., & Knasmüller, S. (1999) · Mutagenesis · doi:10.1093/mutage/14.6.595 · Cited by 100
Benzyl isothiocyanate of papaya fruit
Tang, C.-S. (1971) · Phytochemistry · doi:10.1016/s0031-9422(00)90258-9 · Cited by 99
Inoyama, D., Chen, Y., Huang, X., Beamer, L. J., Kong, A.-N. T., & Hu, L. (2012) · SLAS Discovery · doi:10.1177/1087057111430124 · Cited by 96
Honda, T., Finlay, H. J., Gribble, G. W., Suh, N., & Sporn, M. B. (1997) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(97)00279-5 · Cited by 90
Reversible Michael Additions: Covalent Inhibitors and Prodrugs
H. Johansson, M. (2012) · Mini Reviews in Medicinal Chemistry · doi:10.2174/138955712804586693 · Cited by 89
MacNee, W. (2005) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/156801005774912815 · Cited by 85
Chen, Y., Inoyama, D., Kong, A. T., Beamer, L. J., & Hu, L. (2011) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2011.01240.x · Cited by 83
Shikita, M., Fahey, J. W., Golden, T. R., Holtzclaw, W. D., & Talalay, P. (1999) · Biochemical Journal · doi:10.1042/bj3410725 · Cited by 81
Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis
Iida, K., Itoh, K., Maher, J. M., Kumagai, Y., Oyasu, R., Mori, Y., Shimazui, T., Akaza, H., & Yamamoto, M. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm146 · Cited by 79
Jyrkkänen, H.-K., Kuosmanen, S., Heinäniemi, M., Laitinen, H., Kansanen, E., Mella-Aho, E., Leinonen, H., Ylä-Herttuala, S., & Levonen, A.-L. (2011) · Biochemical Journal · doi:10.1042/bj20110526 · Cited by 78
Senanayake, G. V. K., Banigesh, A., Wu, L., Lee, P., & Juurlink, B. H. J. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.200 · Cited by 74
Nrf2 deficiency influences susceptibility to steroid resistance via HDAC2 reduction
Adenuga, D., Caito, S., Yao, H., Sundar, I. K., Hwang, J.-W., Chung, S., & Rahman, I. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.054 · Cited by 72
Honda, T., Yoshizawa, H., Sundararajan, C., David, E., Lajoie, M. J., Favaloro, F. G., Janosik, T., Su, X., Honda, Y., Roebuck, B. D., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101445p · Cited by 71
Flavour and pharmaceutical properties of the volatile sulphur compounds of Wasabi (Wasabia japonica)
Depree, J. A., Howard, T. M., & Savage, G. P. (1998) · Food Research International · doi:10.1016/s0963-9969(98)00105-7 · Cited by 71
Kappos, L., Gold, R., Miller, D. H., MacManus, D. G., Havrdova, E., Limmroth, V., Polman, C. H., Schmierer, K., Yousry, T. A., Eraksoy, M., et al. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458511421054 · Cited by 65
Zheng, S., Santosh Laxmi, Y. R., David, E., Dinkova-Kostova, A. T., Shiavoni, K. H., Ren, Y., Zheng, Y., Trevino, I., Bumeister, R., Ojima, I., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3003922 · Cited by 62
Liu, G., Eggler, A. L., Dietz, B. M., Mesecar, A. D., Bolton, J. L., Pezzuto, J. M., & van Breemen, R. B. (2005) · Analytical Chemistry · doi:10.1021/ac050892r · Cited by 60
A Synthetic Chalcone as a Potent Inducer of Glutathione Biosynthesis
Kachadourian, R., Day, B. J., Pugazhenti, S., Franklin, C. C., Genoux‐Bastide, E., Mahaffey, G., Gauthier, C., Pietro, A. D., & Boumendjel, A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2016073 · Cited by 59
New treatments and treatment goals for patients with relapsing-remitting multiple sclerosis
Fox, E., & Rhoades, R. W. (2012) · Current Opinion in Neurology · doi:10.1097/01.wco.0000413320.94715.e9 · Cited by 58
Structure−Activity Relationships of Methoxychalcones as Inducers of Heme Oxygenase-1
Sawle, P., Moulton, B. E., Jarzykowska, M., Green, C. J., Foresti, R., Fairlamb, I. J. S., & Motterlini, R. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800115g · Cited by 50
Structural analysis of the complex of Keap1 with a prothymosin α peptide
Padmanabhan, B., Nakamura, Y., & Yokoyama, S. (2008) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309108004995 · Cited by 50
Honda, T., Liby, K. T., Su, X., Sundararajan, C., Honda, Y., Suh, N., Risingsong, R., Williams, C. R., Royce, D. B., Sporn, M. B., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.09.012 · Cited by 48
Isoalantolactone from Inula helenium Caused Nrf2-Mediated Induction of Detoxifying Enzymes
Seo, J. Y., Park, J., Kim, H. J., Lee, I. A., Lim, J.-S., Lim, S. S., Choi, S.-J., Park, J. H. Y., Kang, H. J., & Kim, J. (2009) · Journal of Medicinal Food · doi:10.1089/jmf.2009.0072 · Cited by 47
Wu, K. C., McDonald, P. R., Liu, J. J., Chaguturu, R., & Klaassen, C. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044686 · Cited by 40
Structural Alerts for Toxicity
Blagg, J. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc128 · Cited by 39
GUTERMAN, L. (2011) · Chemical & Engineering News Archive · doi:10.1021/cen-v089n036.p019 · Cited by 39
Phenethyl isothiocyanate-induced cytoskeletal changes and cell death in lung cancer cells
Pawlik, A., Szczepański, M. A., Klimaszewska‐Wiśniewska, A., Gackowska, L., Żuryń, A., & Grzanka, A. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.07.043 · Cited by 37
The Extinguished BEACON of Bardoxolone: Not a Monday Morning Quarterback Story
Tayek, J. A., & Kalantar‐Zadeh, K. (2013) · American Journal of Nephrology · doi:10.1159/000346950 · Cited by 36
Padmanabhan, B., Tong, K. I., Kobayashi, A., Yamamoto, M., & Yokoyama, S. (2008) · Journal of Synchrotron Radiation · doi:10.1107/s090904950705114x · Cited by 31
Oxidative stress and chronic obstructive pulmonary disease
MacNee, W. (2006) · European Respiratory Society eBooks · doi:10.1183/1025448x.00038007 · Cited by 22
Crystallization and initial crystallographic analysis of the Kelch domain from human Keap1
Li, X., Zhang, D., Hannink, M., & Beamer, L. J. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904024825 · Cited by 20
Honda, T., Dinkova‐Kostova, A. T., David, E., Padegimas, E. M., Sundararajan, C., Visnick, M., Bumeister, R., & Wigley, W. C. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.03.018 · Cited by 19
Screening for natural chemoprevention agents that modify human Keap1
Hu, C., Nikolic, D. S., Eggler, A. L., Mesecar, A. D., & van Breemen, R. B. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.10.028 · Cited by 16
Xie, W., Pao, C. S., Graham, T. L., Dul, E., Lu, Q., Sweitzer, T. D., Ames, R. S., & Li, H. (2012) · Assay and Drug Development Technologies · doi:10.1089/adt.2011.436 · Cited by 16
Synthesis and biological activity of novel glycyrrhetic acid derivatives
Salomatina, O. V., Logashenko, E. B., Викторовна, К. Д., Salakhutdinov, N. F., Аркадьевна, З. М., Vlassov, V. V., & Толстиков, Г. А. (2010) · Doklady Chemistry · doi:10.1134/s0012500810020011 · Cited by 4
Honda, T., & al., E. A. E. (2007) · ChemInform · doi:10.1002/chin.200714192 · Cited by 4
Research works printed but not linked: 2
- Johansson M. H., 2012, Mini-Rev. Med. Chem., 12, 1330
- MacNee W., 2005, Curr. Drug Targets, 4, 627
Cited by
The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
Lu, M., Ji, J., Jiang, Z., & You, Q. (2016) · Medicinal Research Reviews · doi:10.1002/med.21396 · Cited by 790
“ARE pathway and their usefulness as potential preventive and therapeutic agents in this journal.12 In a 2013 publication, Wilson et al.13 discussed the development of potential therapies that were based on potent electrophiles, such as isothiocyanates and Michael acceptors, which react covalently…”
BackgroundGehringer, M., & Laufer, S. A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01153 · Cited by 714
Tetrazoles via Multicomponent Reactions
Neochoritis, C. G., Zhao, T., & Dömling, A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00564 · Cited by 599
Activators and inhibitors of NRF2: a review of their potential for clinical development
Robledinos-Antón, N., Fernández-Ginés, R., Manda, G., & Cuadrado, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9372182 · Cited by 413
Targeted Covalent Inhibitors for Drug Design
Baillie, T. A. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601091 · Cited by 578
Metadata
- Authors
- Wilson, A. J., Kerns, J. K., Callahan, J. F., & Moody, C. J.
- Affiliations
- University of Nottingham (GB)
- GlaxoSmithKline (United States) (US)
- Corresponding author
- Moody, Christopher J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-07-25
- Volume
- 56
- Issue
- 19
- Pages
- 7463-7476
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2081058334
- Cited by
- 171
- References
- 140
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 7 · 2023: 10 · 2022: 11 · 2021: 9 · 2020: 17 · 2019: 14 · 2018: 18 · 2017: 14 · 2016: 25 · 2015: 19 · 2014: 11 · 2013: 1
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Keywords
- Nrf2/Keap1 pathway, electrophiles, oxidative stress, isothiocyanates, Michael acceptors, Nrf2 nuclear translocation, chronic kidney disease, chronic obstructive pulmonary disease, asthma, multiple sclerosis, Parkinson's disease, neurodegenerative diseases
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Animals, Cell Nucleus, Esters, Humans, Ketones, Protein Binding, Protein Conformation, Sulfoxides, Isothiocyanates, Active Transport, Cell Nucleus, Intracellular Signaling Peptides and Proteins, NF-E2-Related Factor 2, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.